Mathews Journal of Pharmaceutical Science (MJPS; ISSN: 2474-753X) is international scholarly journal that publishes original research pertaining to diverse pharmaceutical science related topics, such as pro-drug development, drug delivery, drug action, clinical research, drug stability, dosage form design, rational use of pharmacotherapy, metabolic disposition of bioactive agents, targeted drug delivery, regulatory affairs, pharmaceutical biotechnology, pharmacokinetics, pharmacodynamics, ADME, pharmaceutical analysis, bioequivalence and bioavailability, molecular pharmaceutics, biopharmaceutics, microencapsulation, and protein-peptide chemistry with specific focus on pharmaceutical technology.
Special impetus is placed on papers related to drug safety and dealing with topics, such as pharmacoepidemiology, pharmacovigilance, risk management, benefit-risk assessment, and medication error prevention.
This leading journal on the field of Pharmacy and Pharmacology publishes critical reviews, perspectives, commentaries, and original research articles at the interface of disciplines itemized within pharmaceutical and related sciences, and takes great pride in keeping pace with latest research on how drug action/activity may be optimized using new technologies.
Why publish with us?
High Visibility: MJPS follows open access policy, thereby allowing the published articles to be accesses around the globe.
Promotion in Social Media: MJPS believes that serving the authors includes aggressively promoting their articles on social media platforms, and thereby ensuring them higher visibility.
Rigorous peer review: Every manuscript submitted undergoes a thorough and rigorous double-blind peer-review. This process eliminates subjective judgments and bias from the decision making process.
We welcome all types of articles related to Pharmaceutical Science. For submission assistance contact: i[email protected]. Please follow the Author Guidelines.
If you are not sure whether your work is suitable for this journal, please email us at i[email protected] or call us at +1-606-405–6566.
Published : 30th September 2025
Authors : Noor Zulfiqar1,*, Hafiz Muhammad Yameen2, Dua E Hoor3, Gulfam Danish4, Nazeer Manzoor5, Wisha Khan6, Fawad Inam7,8
Citation : Zulfiqar N, et al. (2025). Nanotechnology-Inspired Approaches for Improving the Stability of Cephradine Dry Suspension: The Role of Pharmaceutical Excipients. Mathews J Pharma Sci. 9(3):56.
Published : 30th September 2025
Authors : Suryawanshi Prashant T*, Albhar KG
Citation : Prashant S, et al. (2025). Formulation and Evaluation of Organogels of Actives from Piper Betel for Treatment of Cellulitis. Mathews J Pharma Sci. 9(3):55.
Published : 08th July 2025
Authors : Ezegbe Chekwube Andrew1,3,*, Okorafor Ezinne Chinemerem2, Ogbonna Emmanuel Emeka4, Ezegbe Amarachi Grace5, Olenyi Ogbonna Christantus1
Citation : Andrew EC, et al. (2025). A Review on Recent Advances Using Green Nanotechnological Approaches in the Treatment of Malaria. Mathews J Pharma Sci. 9(3):53.
Published : 26th June 2025
Authors : Ezegbe Chekwube Andrew1,3,*, Ezegbe Amarachi Grace2, Okorafor Ezinne Chinemerem4, Ogbonna Emmanuel Emeka5
Citation : Andrew EC, et al. (2025). Mini Review on the Morphological and Microanalysis Characterization of Chitosan Nanocomposites Using Scanning Electron Microscopy. Mathews J Pharma Sci. 9(3):52.
Published : 30th May 2025
Authors : Ferruccio Trifirò1,#, Paolo Zanirato2,*
Citation : Trifirò F, et al. (2025). The Micro-Reactor: An Opportunity for Re-Evaluation of the Azido Group (N3) in the Syntheses of Nitrogen-Based Drug Products. Mathews J Pharma Sci. 9(3):51.
Published : 14th May 2025
Authors : Mohammad Nadeem Khan*, Ashok Kumar
Citation : Khan MN, et al. (2025). Theranostic Drug Delivery Reinvented: Cyclotron and Nanotechnology Synergy. Mathews J Pharma Sci. 9(2):50.